Johnson & Johnson – Unlocking Urologic Oncology Innovation QuickFire Challenge
Event details
| Date | 03.10.2025 |
| Category | Conferences - Seminars |
Aim: Johnson & Johnson, together with the American Urological Association (AUA), has launched the Unlocking Urologic Oncology Innovation QuickFire Challenge. Innovators from across the globe are invited to submit transformative potential solutions to help improve treatment and care of patients with Bladder and Prostate Cancers. Specific areas of interest are listed below.
Therapeutics:
Funding: up to $300,000
How to Apply: The one-step application process can be completed directly on J&J’s application portal. Only non-confidential information should be provided in the proposal, and anything you submit will be treated as non-confidential.
Deadline: 3 October 2025
Further information
Therapeutics:
- Treatment modalities that limit systemic and on-target, off-tumor toxicities, including local delivery
- Provide organ-sparing treatment options for patients (with advanced disease)
- Focal therapies including but not limited to local energy delivery
- Technologies that improve upon endoscopic procedures such as trans urethral resection of bladder tumor (TURBT)
Funding: up to $300,000
How to Apply: The one-step application process can be completed directly on J&J’s application portal. Only non-confidential information should be provided in the proposal, and anything you submit will be treated as non-confidential.
Deadline: 3 October 2025
Further information
Practical information
- General public
- Free